Home / RPRD2 Knockout Cell Lines

RPRD2 Knockout Cell Lines

Gene: RPRD2

Official Full Name: regulation of nuclear pre-mRNA domain containing 2provided by HGNC

Gene Summary: Predicted to enable RNA polymerase II complex binding activity. Predicted to be involved in mRNA 3'-end processing. Part of transcription preinitiation complex. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO29614 RPRD2 Knockout cell line (HeLa) Human RPRD2 1:3~1:6 Negative Online Inquiry
KO29615 RPRD2 Knockout cell line (HCT 116) Human RPRD2 1:2~1:4 Negative Online Inquiry
KO29616 RPRD2 Knockout cell line (HEK293) Human RPRD2 1:3~1:6 Negative Online Inquiry
KO29617 RPRD2 Knockout cell line (A549) Human RPRD2 1:3~1:4 Negative Online Inquiry

Background

RPRD2 Gene Knockout Cell Lines represent a specialized collection of genetically modified cell lines in which the RPRD2 gene has been systematically disrupted to facilitate in-depth biological studies. RPRD2, involved in various cellular processes including RNA splicing, DNA damage response, and cell cycle regulation, offers critical insights into gene regulation and cellular function. These knockout cell lines enable researchers to investigate the phenotypic consequences of RPRD2 loss, providing a valuable tool for understanding its role in cellular homeostasis and disease pathology.

The RPRD2 gene knockout mechanism employs CRISPR-Cas9 technology, allowing for precise excision of the target gene while minimizing off-target effects. This method ensures that the resultant cell lines are stably modified, maintaining the integrity required for longitudinal studies in both laboratory and therapeutic settings. The ability to produce such knockout models reliably positions these cell lines as indispensable for elucidating RPRD2's impact on tumorigenesis, neurodegenerative disorders, and other pathologies linked to misregulated gene expression.

From a scientific standpoint, RPRD2 Gene Knockout Cell Lines are pivotal in both basic research and translational studies. They can aid in drug discovery, providing a platform for screening potential therapeutics that target pathways influenced by the RPRD2 gene. Moreover, their use can enhance the understanding of complex genetic interactions, making them highly relevant in personalized medicine approaches.

Compared to traditional methods of gene knockout, such as homologous recombination, our RPRD2 Gene Knockout Cell Lines offer a more efficient and time-effective solution with greater specificity and reproducibility. Researchers can capitalize on these advantages, streamlining their studies and facilitating more rigorous experimentation.

For scientists and clinicians focused on genetic research, cell biology, or translational applications, these cell lines offer exceptional value, supporting innovative investigations and paving the way for novel therapeutic strategies. Our company harnesses extensive expertise in genetic engineering and cell line development, ensuring that our offerings are at the forefront of biological research tools. With RPRD2 Gene Knockout Cell Lines, we empower researchers to unlock new discoveries that can transform our understanding of biology and disease.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.